Drug Marketers Are Finding Creative Applications For SGLT-2 Drugs Ignoring The Risk of Fournier's Gangrene
Drug marketers highlight any benefit they can find to incentivize doctors to prescribe sodium-glucose blocker drugs to their diabetic patients but ignore the link to Fournier's Gangrene, a form of genital necrotizing fasciitis by the FDA
Thursday, October 24, 2019 - Type 2 diabetic patients that do not wish to physically inject themselves with insulin several times per day may opt to take a sodium-glucose blocker drug (SGLT-2) to regulate their blood sugar level. SGLT-2 drugs work by preventing the SGLT-2 protein from transferring glucose filtered in the kidneys back into the bloodstream and instead redirect it out of the body through the urine. SGLT-2 drugs have the added benefits of helping to lower blood pressure and to aid in weight loss. The drugs are also being touted by drug companies for preventing kidney failure, lowering blood pressure, and a whole host of miraculous achievements. Drug marketing websites are seizing on studies and reports to use a tool to sell more SGLT2 drugs. National diabetes drug infection attorneys are available to answer your questions about Fournier necrotizing fasciitis. Fournier gangrene lawsuits handled by top national attorneys with a distinguished record having won major settlements against multinational pharmaceutical conglomerates on behalf of American families harmed by dangerous drugs and defective medical devices.
While most studies are inconclusive and only suggestive, one published in The Lancet, Diabetes & Endocrinology reported that sodium-glucose blocker drugs can lower the instances of kidney failure in diabetic patients. "SGLT2 inhibitors reduced the risk of dialysis, transplantation, or death due to kidney disease in individuals with type 2 diabetes and protected against acute kidney injury. These data provide substantive evidence supporting the use of SGLT2 inhibitors to prevent major kidney outcomes in people with type 2 diabetes."
Invokana is the leading SGLT2 blocker drug and boasts on the top of their home page of the ancillary benefits of taking the diabetic drug. "Now Approved-The only type 2 diabetes medicine proven to lower the risks of end-stage kidney disease (ESKD), worsening of kidney function, cardiovascular death, hospitalization for heart failure in adults with type 2 diabetes and diabetic kidney disease." The home page goes on to make patients aware of how critical diabetic kidney disease can be and that "Nearly 1 in 3 adults with type 2 diabetes has diabetic kidney."
Such impressive benefits are not without risks, however, and there have been some SGLT2 diabetic patients that have developed Fournier's Gangrene, a rare but often deadly form of the flesh-eating disease that consumes one's genitals. SGLT-2 blocker drugs that the FDA has linked with Fournier's Gangrene include canagliflozin (Invokana), canagliflozin/metformin (Invokamet), and dapagliflozin (Farxiga). Treatments for Fournier's Gangrene usually require genital amputation or mutilation for men. There have been 55 reported cases of Fournier's Gangrene and that number could be much greater because so few doctors and even fewer diabetic patients have ever heard of the condition where the connection to diabetic drugs is usually overlooked. If you have developed genital pain and swelling you should immediately see a doctor but continue to take your diabetes medication until your doctor advises otherwise.
More Recent Diabetes Drug Infection Lawsuit News:
- Heart Disease Patients May Soon Be Prescribed Farxiga | 7/23/2020
- Diabetic Drug Farxiga Emerges As A Potential Cause of Fournier's Gangrene | 7/20/2020
- Diabetic Drug Companies Fail To Adequately Warn Patients of The Dangers of Developing Fournier's Gangrene | 7/15/2020
- A High Profile Fournier's Gangrene Victim May Serve To Increase Public Awareness | 6/25/2020
- The Flesh-Eating Disease Could Grow Exponentially in Summer of 2020 | 6/16/2020
- AstraZeneca Pharmaceutical Web Site Warns Patient About Possible Bacterial Infections | 6/5/2020
- New Fournier's Gangrene Victim Files Lawsuit Against AstraZeneca Pharmaceuticals LP | 6/3/2020
- Fornier's Gangrene is Easily Overlooked And Could be Called Complications From the Coronavirus | 5/26/2020
- Diabetic Nursing Home Patients May Be Dying From Fournier's Gangrene | 5/15/2020
- Diabetic Patients Taking SGLT2 Diabetic Drugs Could Be At Risk of Dying from COVID19 | 4/27/2020
- Fournier's Gangrene Looks Like Frostbite Except For Its Location | 4/21/2020
- Fournier's Gangrene More Likely Than Nursing Home Neglect In Patient's Death | 4/9/2020
- Nursing Homes Need To Pay Attention To Diabetic Patients Developing Fournier's Gangrene | 3/31/2020
- New Warning For SGLT2 Diabetes Drugs Include Fournier's Gangrene | 3/19/2020
- Popular Diabetic Drug Companies Are Warned To Alert Diabetic Patients of the Risks of Developing Fournier's Gangrene | 3/12/2020
- Patient's Fournier's Gangrene Can Be Mistaken For Ordinary Nursing Home Neglect | 3/5/2020
- Nursing Home Patients Taking Diabetic Medication Must Be Monitored For Fournier's Gangrene | 2/25/2020
- Simple Necrotizing Fasciitis Can Lead To Gruesome Fournier's Gangrene | 2/7/2020
- Fournier's Gangrene Can Cause Elephantitis of the Scrotum | 2/3/2020
- Diabetic Drugs Linked to Fournier's Gangrene May Treat Heart Conditions | 1/29/2020
- The Annals of Medicine Examines the Relationship Between Certain Diabetic Drugs and Fournier's Gangrene | 1/8/2020
- Diabetic Medications Can Cause Fournier's Gangrene And Other Health-Threatening Conditions | 12/31/2019
- Fournier's Gangrene Can Leave a Survivor Severely Depressed | 12/20/2019
- Woman's Cosmetic Surgery Leads to Flesh-Eating Disease of the Genitals | 12/16/2019
- Women Diagnosed With Orbital Necrotizing Fasciitis | 12/2/2019
- The Flesh-Eating Disease Has Made The News In 2019 | 11/22/2019
- Diabetic Drugs Can Weaken The Immune System Leading To Fournier's Gangrene | 11/11/2019
- SGLT-2 Drug Makers Are Being More Forthcoming About Links To Fournier's Gangrene | 10/31/2019
- Patient Contracts Flesh-Eating Disease While Giving Birth in a New York Hospital | 10/15/2019
- Weakened Immune Systems May Be The Cause of The Outbreak in Flesh-Eating Disease | 10/3/2019
- Fournier's Gangrene Stories Are One More Shocking Than Then The Last | 10/2/2019
- Sodium-Glucose Blocker Drugs and The Flesh-Eating Disease | 9/18/2019
- Diabetic Patients Are At Risk For Developing Fournier's Gangrene Mistaken as The Ordinary Flesh-Eating Disease | 9/2/2019
- SGLT2 Inhibitor Drugs Can Now Include Reducing Heart Disease on Their Labels In Europe | 8/29/2019
- Fournier's Gangrene Can Develop In Elderly Nursing Home Patients | 8/23/2019
- Elderly Diabetic Patients Are At Risk For Fournier's Gangrene | 8/7/2019
- Florida Nursing Home Death May Have Been From Fournier's Gangrene | 8/1/2019
- There is an Outbreak of The Flesh-Eating Disease Along America's Eastern Beaches | 7/23/2019
- Fournier's Gangrene Should Not Be Confused With Everyday Necrotising Fasciitis | 7/11/2019
- Johnson & Johnson Needs To Do More To Alert Diabetics of The Flesh Eating Disease Caused By Invokana | 6/28/2019
- Diabetic Patients Living in Warmers Climates Are More at Risk to Contract Fournier's Gangrene | 6/13/2019
- The Warm Water Gulf of Mexico May Be a Breeding Ground For The Flesh Eating Disease Bacteria | 6/7/2019
- Diabetic Patients in Nursing Homes Are Ground Zero For Fournier's Gangrene | 5/30/2019
- Several New Cases Of Flesh Eating Disease Have Been Recently Reported | 5/23/2019
- Cases Of Fournier's Gangrene Increases From 12 to 55 In The Latest Peer Reviewed Medical Study | 5/13/2019
- People Are Developing The Flesh-Eating Disease In Various Ways | 4/30/2019
- Most Doctors Remain Unaware of Fournier's Gangrene and May Misdiagnose Patients | 4/19/2019
- World Governments Are Expressing Concern That Certain Diabetes Drugs Can Cause Fournier's Gangrene | 4/15/2019
- Diabetic Drugs Can Have Serious Side Effects | 4/2/2019
- Necrotising Fasciitis Effects Everyone From All Walks of Life | 3/29/2019
- Cases of Fourniers Gangrene Are Steadily Increasing Around The World | 3/25/2019
- Global Warming and Climate Change May Be Contributing to Increases In Flesh Eating Diseases | 3/11/2019
- Early Warning Signs That You May Have Fournier's Gangrene or Other Flesh-Eating Disease | 3/6/2019
- Scientists Are Encouraged By Data From Flesh-Eating Disease Studies | 2/25/2019
- The Brief History of Fournier's Gangrene | 2/20/2019
- FDA and CDC Warn About Flesh-Eating Diseases | 2/18/2019
- Diabetic Drug Warnings Admit to Causing Narcotizing Fasciitis Not Fournier's Gangrene Specifically | 2/11/2019
- Fournier's Gangrene Statistics May Be Greater Than Reported | 2/5/2019
- Diabetic Patients and Others Are At Risk For Fournier's Gangrene | 1/29/2019
- Fournier's Gangrene Frequently Asked Questions | 1/23/2019
- Diabetes Drugs Must Include Fournier's Gangrene Warning | 1/18/2019
- A Nursing Home's Elderly Diabetic Population Most at Risk For Fournier's Gangrene | 1/10/2019
- Diabetic Patients Should Be Vigilant In Watching For The Symptoms Of Fournier's Gangrene, A Flesh-Eating Disease That Can Affect The Genital Region | 1/4/2019
- An Indian Man Has Died of Fournier's Gangrene in a UK Hospital | 12/31/2018
- Pictures of Fournier's Gangrene Are Grotesque and Indescribable | 12/22/2018
- A Florida Nursing Home Patient Death Could be the 13th Case of Fournier's Gangrene | 12/20/2018
- Florida Man Dies From Genital Gangrene Quite Possibly Fournier's Gangrene | 12/15/2018
- The FDA's Fournier's Gangrene Warning is Shocking Diabetes Patients | 12/12/2018
- Drug Websites Carry The Clearest Fournier's Gangrene Amputation Warnings | 12/1/2018
- Recent FDA Warning Alerts Diabetes Patients To Watch For Signs of Genital Flesh-Eating Disease | 11/21/2018
- Diabetes Drugs May Cause Flesh-Eating Disease Affecting The Genitals | 11/1/2018
Lawyers for Fournier's Gangrene
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.